SentrX™ LeadershipRichard K. Koehn, Ph.D.
Co-founder, President and Chief Executive Officer
A consultant to the venture capital business for over 15 years, Dr. Koehn was Entrepeneur of the Year in 1991. As CEO of Salus Therapeutics, he negotiated its acquisition by Genta, Inc. In 2005, Dr. Koehn negotiated a $7.5M investment in SentrX Surgical, Inc. leading to the creation of Carbylan BioSurgery, Inc.; Glycosan Biosystems, Inc.; and SentrX™ Animal Care, Inc. Founding Director of the Center for Advanced Biomedical Technology in NY, and Vice President of Research at the University of Utah (1992-2000), in 2005, Dr. Koehn was awarded the Governor's Medal in Science and Technology.
Brenda K. Mann, Ph.D.
Co-founder and Vice President
B.Sc. (1991), Chemical Engineering, Iowa State University; Ph.D. (1997), Chemical Engineering, Rice University. Dr. Mann has extensive experience in the development of hydrogels for tissue engineering and wound healing applications. She received the Rice University Outstanding Woman Award in 1996, and the Young Investigator Award from the International Society for Applied Cardiovascular Biology in 2000. Dr. Mann was a founding faculty member of the Keck Graduate Institute of Applied Life Sciences, and now serves on its Advisory Council. She is a Research Assistant Professor in the Department of Bioengineering at the University of Utah, and holds an adjunct faculty position at the University of Texas at El Paso. Dr. Mann is also a registered patent agent.
Sarah K. Atzet, Ph.D.
Chief Operating Officer
B.Sc. (2002), Chemical Engineering, University of Utah; M.S. (2004), Chemical Engineering, University of Washington; Ph.D. (2008), Chemical Engineering, University of Washington. Dr. Atzet has considerable experience in the development and testing of biomaterials for medical applications. Prior to joining SentrX™ Animal Care, Inc., she was Director of Research & Development at Glycosan BioSystems, Inc. (Salt Lake City, UT). Dr. Atzet also holds an adjunct faculty position in the Department of Chemical Engineering at the University of Utah.
Glenn D. Prestwich, Ph.D.
Co-founder and Senior Scientific Advisor
Presidential Professor of Medicinal Chemistry, The University of Utah (1996-present); B.Sc. (1970), Chemistry, California Institute of Technology; Ph.D. (1974), Chemistry, Stanford University; Alfred P. Sloan Research and Dreyfus Teacher-Scholar Awards; 1998 Paul Dawson Biotechnology Award (AACP); Fellow of American Institute for Medical and Biological Engineering Professor of Chemistry, Stony Brook University (1977-1996); Director, Center for Biotechnology (Stony Brook, 1992-1996); Director, Center for Cell Signaling (2002-2007); Director, Center for Therapeutic Biomaterials (2004-present). Co-founder and former CSO, Eschelon Biosciences, Inc. (Salt Lake City, UT); Co-founder and former CSO, SentrX Surgical, Inc.; Senior Scientific Advisor, Carbylan BioSurgery, Inc. (Palo Alto, CA); Co-founder and former CSO, Glycosan Biosystems, Inc. (Salt Lake City, UT). Dr. Prestwich has published over 556 papers, patents, and book chapters; additionally, he has trained over 69 graduate students and 53 postdocs over the course of 30+ years.